Cargando…
PRP4 Kinase Domain Loss Nullifies Drug Resistance and Epithelial-Mesenchymal Transition in Human Colorectal Carcinoma Cells
We have investigated the involvement of the pre-mRNA processing factor 4B (PRP4) kinase domain in mediating drug resistance. HCT116 cells were treated with curcumin, and apoptosis was assessed based on flow cytometry and the generation of reactive oxygen species (ROS). Cells were then transfected wi...
Autores principales: | Ahmed, Muhammad Bilal, Islam, Salman Ul, Sonn, Jong Kyung, Lee, Young Sup |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Molecular and Cellular Biology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398799/ https://www.ncbi.nlm.nih.gov/pubmed/32576716 http://dx.doi.org/10.14348/molcells.2020.2263 |
Ejemplares similares
-
PRP4 Induces Epithelial–Mesenchymal Transition and Drug Resistance in Colon Cancer Cells via Activation of p53
por: Islam, Salman Ul, et al.
Publicado: (2022) -
PRPF overexpression induces drug resistance through actin cytoskeleton rearrangement and epithelial-mesenchymal transition
por: Islam, Salman Ul, et al.
Publicado: (2017) -
Decursin negatively regulates LPS-induced upregulation of the TLR4 and JNK signaling stimulated by the expression of PRP4 in vitro
por: Ahmed, Muhammad Bilal, et al.
Publicado: (2020) -
PRP4 Promotes Skin Cancer by Inhibiting Production of Melanin, Blocking Influx of Extracellular Calcium, and Remodeling Cell Actin Cytoskeleton
por: Ahmed, Muhammad Bilal, et al.
Publicado: (2021) -
Lifespan reduction due to neoplasia is nullified by pseudoexfoliation syndrome
por: Slettedal, Jon Klokk, et al.
Publicado: (2018)